A detailed history of Primecap Management CO transactions in Cerus Corp stock. As of the latest transaction made, Primecap Management CO holds 8,584,000 shares of CERS stock, worth $15.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,584,000
Previous 8,613,000 0.34%
Holding current value
$15.4 Million
Previous $18.6 Million 12.8%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$1.66 - $2.42 $48,140 - $70,180
-29,000 Reduced 0.34%
8,584,000 $16.2 Million
Q2 2023

Aug 11, 2023

SELL
$1.79 - $2.9 $363,549 - $588,990
-203,100 Reduced 2.3%
8,613,000 $21.2 Million
Q1 2023

May 15, 2023

SELL
$2.65 - $3.81 $88,775 - $127,635
-33,500 Reduced 0.38%
8,816,100 $26.2 Million
Q4 2022

Feb 13, 2023

SELL
$3.38 - $4.22 $1.42 Million - $1.77 Million
-418,900 Reduced 4.52%
8,849,600 $32.3 Million
Q2 2022

Aug 11, 2022

SELL
$4.41 - $5.69 $1.16 Million - $1.5 Million
-264,100 Reduced 2.77%
9,268,500 $49 Million
Q1 2022

May 11, 2022

SELL
$4.81 - $6.99 $912,456 - $1.33 Million
-189,700 Reduced 1.95%
9,532,600 $52.3 Million
Q4 2021

Feb 11, 2022

SELL
$5.97 - $7.93 $1.73 Million - $2.3 Million
-289,600 Reduced 2.89%
9,722,300 $66.2 Million
Q3 2021

Nov 12, 2021

SELL
$4.79 - $6.68 $508,698 - $709,416
-106,200 Reduced 1.05%
10,011,900 $61 Million
Q2 2021

Aug 10, 2021

SELL
$5.35 - $6.35 $369,685 - $438,785
-69,100 Reduced 0.68%
10,118,100 $59.8 Million
Q1 2021

May 14, 2021

SELL
$5.68 - $7.87 $1.4 Million - $1.95 Million
-247,300 Reduced 2.37%
10,187,200 $61.2 Million
Q4 2020

Feb 08, 2021

SELL
$5.25 - $8.56 $1.76 Million - $2.87 Million
-335,600 Reduced 3.12%
10,434,500 $72.2 Million
Q3 2020

Nov 13, 2020

SELL
$5.78 - $7.47 $2.43 Million - $3.14 Million
-419,900 Reduced 3.75%
10,770,100 $67.4 Million
Q2 2020

Aug 13, 2020

SELL
$4.5 - $7.02 $44,100 - $68,796
-9,800 Reduced 0.09%
11,190,000 $73.9 Million
Q1 2020

May 14, 2020

SELL
$2.87 - $5.49 $287,574 - $550,098
-100,200 Reduced 0.89%
11,199,800 $52.1 Million
Q2 2019

Aug 14, 2019

BUY
$4.51 - $6.6 $2.26 Million - $3.3 Million
500,000 Added 4.63%
11,300,000 $63.5 Million
Q4 2018

Feb 12, 2019

BUY
$4.89 - $7.16 $2.45 Million - $3.58 Million
500,000 Added 4.85%
10,800,000 $54.8 Million
Q1 2018

May 14, 2018

BUY
$3.56 - $5.74 $8.9 Million - $14.4 Million
2,500,000 Added 32.05%
10,300,000 $56.4 Million
Q3 2017

Nov 13, 2017

BUY
$2.22 - $2.73 $17.3 Million - $21.3 Million
7,800,000
7,800,000 $21.3 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.